SCHEMBL25849295

SCHEMBL25849295

c1ccc(-c2ccc(N(c3cccc(-c4ccccc4)c3)c3ccc4c(c3)sc3cccc(-c5nc(-c6ccccc6)c6ccccc6n5)c34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ATM Q13315 1/20 0.38
NUDT1 P36639 2/20 0.34
PDK1 Q15118 4/20 0.34
ADORA2A P29274 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.31
KDM1A O60341 1/20 0.31
PDE5A O76074 2/20 0.31
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
GLA P06280 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26420502 0.97 MEN1 (0.40) MEN1KMT2AATMNUDT1PDK1
SCHEMBL26420626 0.93 MEN1 (0.38) MEN1KMT2AATMNUDT1PDK1
SCHEMBL26420641 0.93 MEN1 (0.39) MEN1KMT2AATMNUDT1PDK1
SCHEMBL26415707 0.89 MEN1 (0.41) MEN1KMT2AATMNUDT1PDK1
SCHEMBL26420495 0.88 LIMK1 (0.33) MEN1KMT2AADORA2AABCG2MAPT
SCHEMBL25853441 0.87 LIMK1 (0.33) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL25849400 0.87 LIMK1 (0.32) ADORA2AABCG2TSHRLIMK1
SCHEMBL26420483 0.85 LIMK1 (0.32) MEN1KMT2AADORA2AABCG2KDM1A
SCHEMBL26420515 0.85 LIMK1 (0.32) MEN1KMT2AADORA2AABCG2KDM1A
SCHEMBL26420480 0.85 LIMK1 (0.32) MEN1KMT2AADORA2AABCG2KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4206198-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 MEN1 1044/4885KMT2A 1149/4885ATM 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.